Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is 17.11% vs 4.62% in Sep 2025
Consolidate Net Profit
YoY Growth in quarter ended Sep 2026 is 2.60% vs 77.52% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is 8.36% vs 25.44% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is 0.89% vs -37.51% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025
Compare Quarterly Results Of Strides Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 12.99% vs -4.39% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 17.11% vs 4.62% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is -16.61% vs 23.61% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 2.60% vs 77.52% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 9.20% vs -4.14% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 8.36% vs 25.44% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 14.74% vs -2.45% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 0.89% vs -37.51% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026
YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025